Copyright
©The Author(s) 2024.
World J Clin Cases. May 26, 2024; 12(15): 2499-2505
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2499
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2499
Table 1 Characteristics of the participants
| Primary site | n | Median survival time (95%CI, month) |
| CUP | 31 | 8.6 (1-16) |
| Gastric cancer | 24 | 6.0 (5-7) |
| Colorectal cancer | 21 | 8.5 (6-11) |
| Sarcoma | 10 | 9.2 (0-24) |
| Pancreatic cancer | 9 | 9.3 (3-16) |
| NET | 7 | 4.0 (2-7) |
| Esophageal cancer | 6 | 2.9 (1-4) |
| Skin cancer | 4 | 34.7 (4-66) |
| Thymic cancer | 3 | 14.0 (14-14) |
| Hematologic malignancy | 3 | Not reached |
| Urological cancer | 3 | 8.1 (0-17) |
| Others | 6 | 6.4 (3-10) |
| Overall | 136 | 8.1 (6-10) |
Table 2 Historical comparison of survival outcomes between the periods ranging from 2005 to 2008 and 2020 to 2023
| NKSS | n | 1-yr-survival rate in this study (2010-2023) (95%CI) | 1-yr-survival rate in the original study (2005-2008) (95%CI) |
| 0-3 | 3 | - | 91.4 (85.9–96.9) |
| 4-6 | 62 | 56 (43-70) | 49.3 (44.0-54.6) |
| 7-10 | 71 | 20 (10-31) | 6.0 (3.5–8.5) |
- Citation: Matsuda K, Shimazu K, Shinozaki H, Fukuda K, Yoshida T, Taguchi D, Nomura K, Shibata H. Recent trends in bone metastasis treatments: A historical comparison using the new Katagiri score system. World J Clin Cases 2024; 12(15): 2499-2505
- URL: https://www.wjgnet.com/2307-8960/full/v12/i15/2499.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i15.2499